Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1

Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8542, Development and Evolution of the Nervous System, Group Development and Neuropharmacology, Ecole Normale Supérieure, 75230 Paris Cedex 05, France.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 02/2007; 27(5):1063-71. DOI: 10.1523/JNEUROSCI.4583-06.2007
Source: PubMed

ABSTRACT Engrailed1 and Engrailed2 (En1 and En2) are two developmental genes of the homeogene family expressed in the developing midbrain. En1 and, to a lesser degree, En2 also are expressed in the adult substantia nigra (SN) and ventral tegmental area (VTA), two dopaminergic (DA) nuclei of the ventral midbrain. In an effort to study En1/2 adult functions, we have analyzed the phenotype of mice lacking one En1 allele in an En2 wild-type context. We show that in this mutant the number of DA neurons decreases slowly between 8 and 24 weeks after birth to reach a stable 38 and 23% reduction in the SN and VTA, respectively, and that neuronal loss can be antagonized by En2 recombinant protein infusions in the midbrain. These loss and gain of function experiments firmly establish that En1/2 is a true survival factor for DA neurons in vivo. Neuronal death in the mutant is paralleled by a 37% decrease in striatal DA, with no change in serotonin content. Using established protocols, we show that, compared with their wild-type littermates, En1+/- mice have impaired motor skills, an anhedonic-like behavior, and an enhanced resignation phenotype; they perform poorly in social interactions. However, these mice do not differ from their wild-type littermates in anxiety-measuring tests. Together, these results demonstrate that En1/2 genes have important adult physiological functions. They also suggest that mice lacking only one En1 allele could provide a novel model for the study of diseases associated with progressive DA cell death.

Download full-text


Available from: Gwenaëlle Le Pen, Aug 22, 2015
  • Source
    • "The most notable phenotype was observed in En1 (+/−)/En2 (+/+) mutant mice, which display a progressive degeneration (between 8 and 24 weeks) of VM DA neurons that can be antagonised by recombinant En2 protein infusion (Sonnier et al., 2007). The progressive degeneration of VM DA neurons in En1 heterozygotes (En2 null background in Sgado et al. (2006) study) is more pronounced in the SNc and results in reduced striatal DA and motor deficits, as is characteristic of PD pathology (Sgado et al., 2006; Sonnier et al., 2007). These findings further support the theory that En1/En2 function as important survival-promoting factors for VM DA neurons. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dopaminergic (DA) neurons of the ventral midbrain (VM) play vital roles in the regulation of voluntary movement, emotion and reward. They are divided into the A8, A9 and A10 subgroups. The development of the A9 group of DA neurons is an area of intense investigation to aid the generation of these neurons from stem cell sources for cell transplantation approaches to Parkinson's disease (PD). This review discusses the molecular processes that are involved in the identity, specification, maturation, target innervation and survival of VM DA neurons during development. The complex molecular interactions of a number of genetic pathways are outlined, as well as recent advances in the mechanisms that regulate subset identity within the VM DA neuronal pool. A thorough understanding of the cellular and molecular mechanisms involved in the development of VM DA neurons will greatly facilitate the use of cell replacement therapy for the treatment of PD.
    Developmental Biology 04/2013; 379(2). DOI:10.1016/j.ydbio.2013.04.014 · 3.64 Impact Factor
  • Source
    • "Bcl-X L effects on maturation are marginal, as discussed later. EN1, LMX1B, NURR1 and PITX3 are not only involved in development, but also in the survival/maintenance of functional A9-DAn ([50] [51] [52] [53] [54] reviewed in [6] [15] [24] [49] [77]). In control hVM1 cells the expression levels of these genes first increase during differentiation (but for PITX3), to later return to values close to basal levels (Fig. 3A and Fig. 5A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Understanding the molecular programs of the generation of human dopaminergic neurons (DAn) from their ventral mesencephalic (VM) precursors is of key importance for basic studies, progress in cell therapy, drug screening and pharmacology in the context of Parkinson's disease. The nature of human DAn precursors in vitro is poorly understood, their properties unstable, and their availability highly limited. Here we present positive evidence that human VM precursors retaining their genuine properties and long-term capacity to generate A9 type Substantia nigra human DAn (hVM1 model cell line) can be propagated in culture. During a one month differentiation, these cells activate all key genes needed to progress from pro-neural and pro-dopaminergic precursors to mature and functional DAn. For the first time, we demonstrate that gene cascades are correctly activated during differentiation, resulting in the generation of mature DAn. These DAn have morphological and functional properties undistinguishable from those generated by VM primary neuronal cultures. In addition, we have found that the forced expression of Bcl-X(L) induces an increase in the expression of key developmental genes (MSX1, NGN2), maintenance of PITX3 expression temporal profile, and also enhances genes involved in DAn long-term function, maintenance and survival (EN1, LMX1B, NURR1 and PITX3). As a result, Bcl-X(L) anticipates and enhances DAn generation.
    Experimental Cell Research 08/2012; 318(19):2446-59. DOI:10.1016/j.yexcr.2012.07.018 · 3.37 Impact Factor
  • Source
    • "The test was performed as previously described (Sonnier et al., 2007; De Chiara et al., 2010b). DAT-CI and control mice (n = 8 per sucrose concentration), placed in individual cages 2 weeks before the test, were subjected to a water vs. sucrose two-bottle preference test. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abnormal dopamine (DA) transmission in the striatum plays a pivotal role in attention-deficit/hyperactivity disorder (ADHD). As striatal DA signalling modulates the endocannabinoid system (ECS), the present study was aimed at investigating cannabinoid CB1 receptor (CB1R) function in a model of ADHD obtained by triple point-mutation in the dopamine transporter (DAT) gene in mice, making them insensitive to cocaine [DAT cocaine-insensitive (DAT-CI) mice]. DAT-CI mice had a marked hyperactive phenotype, and neurophysiological recordings revealed that the sensitivity of CB1Rs controlling GABA-mediated synaptic currents [CB1Rs((GABA)) ] in the striatum was completely lost. In contrast, CB1Rs modulating glutamate transmission [CB1Rs((Glu)) ], and GABA(B) receptors were not affected in this model of ADHD. In DAT-CI mice, the blockade of CB1R((GABA)) function was complete even after cocaine or environmental manipulations activating the endogenous DA-dependent reward system, which are known to sensitize these receptors in control animals. Conversely, the hedonic property of sucrose was intact in DAT-CI mice, indicating normal sweet perception in these animals. Our results point to CB1Rs as novel molecular players in ADHD, and suggest that therapeutic strategies aimed at interfering with the ECS might prove effective in this disorder.
    European Journal of Neuroscience 11/2011; 34(9):1369-77. DOI:10.1111/j.1460-9568.2011.07876.x · 3.67 Impact Factor
Show more